arrow_back Back to App

New Restrictions on Abortion Drugs: Approvals and Use

This act prohibits the approval of new abortion drugs and their investigational use. It also imposes strict new regulations on already approved abortion drugs, including requiring in-person administration by a healthcare practitioner and additional qualifications for prescribers. The aim is to enhance patient safety and restrict access to these medications.
Key points
Prohibits the approval of new abortion drugs and their use in investigations.
Existing abortion drugs must be administered in-person by a healthcare practitioner in a clinic, medical office, or hospital, not in pharmacies.
Healthcare practitioners prescribing abortion drugs must be certified, demonstrating ability to assess pregnancy duration, diagnose ectopic pregnancies, and provide surgical intervention.
Mandatory reporting of all adverse events, including fatalities and hospitalizations, associated with abortion drug use.
article Official text account_balance Process page
Introduced
Citizen Poll
No votes cast
Additional Information
Print number: 119_HR_685
Sponsor: Rep. Latta, Robert E. [R-OH-5]
Process start date: 2025-01-23
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

SAVE Moms and Babies Act of 2025

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_HR_685.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2025-01-23.

What are the main provisions?

Key points include:

  • Prohibits the approval of new abortion drugs and their use in investigations.
  • Existing abortion drugs must be administered in-person by a healthcare practitioner in a clinic, medical office, or hospital, not in pharmacies.
  • Healthcare practitioners prescribing abortion drugs must be certified, demonstrating ability to assess pregnancy duration, diagnose ectopic pregnancies, and provide surgical intervention.
  • Mandatory reporting of all adverse events, including fatalities and hospitalizations, associated with abortion drug use.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Latta, Robert E. [R-OH-5].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Energy and Commerce.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-23.

CATEGORIES

Health